ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 52 filers reported holding ANAPTYSBIO INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $10,000,000 | +2773.6% | 203 | -98.0% | 0.10% | +33.3% |
Q1 2022 | $348,000 | 0.0% | 10,000 | 0.0% | 0.08% | 0.0% |
Q4 2021 | $348,000 | +28.4% | 10,000 | 0.0% | 0.08% | +20.0% |
Q3 2021 | $271,000 | +4.6% | 10,000 | 0.0% | 0.06% | -4.4% |
Q2 2021 | $259,000 | +19.9% | 10,000 | 0.0% | 0.07% | +19.3% |
Q1 2021 | $216,000 | +0.5% | 10,000 | 0.0% | 0.06% | -3.4% |
Q4 2020 | $215,000 | +45.3% | 10,000 | 0.0% | 0.06% | +22.9% |
Q3 2020 | $148,000 | -34.8% | 10,000 | 0.0% | 0.05% | -36.0% |
Q2 2020 | $227,000 | +62.1% | 10,000 | 0.0% | 0.08% | +17.2% |
Q1 2020 | $140,000 | -14.1% | 10,000 | 0.0% | 0.06% | +8.5% |
Q4 2019 | $163,000 | -53.4% | 10,000 | 0.0% | 0.06% | -63.6% |
Q3 2019 | $350,000 | -60.5% | 10,000 | +17.6% | 0.16% | -53.0% |
Q1 2018 | $885,000 | -48.3% | 8,500 | -50.0% | 0.34% | -42.8% |
Q4 2017 | $1,711,000 | -38.7% | 17,000 | -83.1% | 0.60% | -43.5% |
Q1 2017 | $2,789,000 | – | 100,500 | – | 1.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $81,462,731 | 11.84% |
EcoR1 Capital, LLC | 7,521,024 | $233,076,534 | 7.09% |
5AM Venture Management, LLC | 357,733 | $11,086,146 | 2.98% |
Boxer Capital, LLC | 1,300,000 | $40,287,000 | 2.12% |
Frazier Life Sciences Management, L.P. | 899,700 | $27,881,703 | 1.73% |
Palo Alto Investors LP | 431,024 | $13,357,434 | 1.14% |
Logos Global Management LP | 250,000 | $7,747,500 | 0.91% |
BRAIDWELL LP | 726,122 | $22,502,521 | 0.75% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,161,826 | $36,004,988 | 0.74% |
Rock Springs Capital Management LP | 576,600 | $17,868,834 | 0.43% |